
|Videos|February 2, 2021
Clinical care pathway demonstrates efficacy for patients with overactive bladder
Author(s)Urology Times staff
Chris Du, MD, discusses findings from a study published in Neurourology and Urodynamics.
Advertisement
In this interview, Chris Du, MD, discusses findings from the Neurourology and Urodynamics paper, A retrospective longitudinal evaluation of new overactive bladder patients in an FPMRS urologist practice: Are patients following up and utilizing third‐line therapies?, for which he served as a study author. Du is a urology resident at Stony Brook University, Stony Brook, New York.
More videos:
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
CMS' 2027 PFS proposed rule: Modifier -25 cuts, G2211 overhaul loom
2
The UroOnc Minute: Cribriform Histology in Prostate Cancer, With Tyler Seibert, MD, PhD
3
Rezūm shows greater 1-year BPH symptom relief vs pharmacotherapy
4
FDA grants breakthrough therapy, fast track designations to kidney cancer imaging agent
5










